NHSE - SEL Provision of Covid-19 Vaccination Services

{
  "id": "013955-2025",
  "tag": [
    "award",
    "contract"
  ],
  "bids": {
    "statistics": [
      {
        "id": "2",
        "value": 1,
        "measure": "bids",
        "relatedLot": "1"
      }
    ]
  },
  "date": "2025-04-09T13:16:12+01:00",
  "ocid": "ocds-h6vhtk-04ff9f",
  "buyer": {
    "id": "GB-NHS-Q71",
    "name": "NHS England (London Region)"
  },
  "awards": [
    {
      "id": "013955-2025-1",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-NHS-RJ1",
          "name": "GUY'S AND ST THOMAS' NHS FOUNDATION TRUST"
        }
      ],
      "relatedLots": [
        "1"
      ]
    }
  ],
  "tender": {
    "id": "PRJ2171",
    "lots": [
      {
        "id": "1",
        "status": "cancelled",
        "hasOptions": false,
        "description": "NHSE - SEL Provision of Covid-19 Vaccination Services.\nTo provide an outreach vaccination service targeted at the underserved and core 20 plus 5 populations of   South East London.   \nThe Provider must endeavour to deliver the Vaccination Outreach Services through flexible community led delivery models to improve uptake and engagement with communities. Processes where possible should support patients with communication needs and/or encourage vaccination of patients who experience other difficulties in accessing healthcare. \nThe SEL outreach vaccination service is dedicated to reaching a broad and diverse population across the ICB's geographical footprint with the aim of providing equitable access to COVID-19 and other vaccinations for all residents, regardless of their location, age, ethnicity or socioeconomic status. \nCOVID-19 vaccinations are currently commissioned with providers under an enhanced service agreement overseen by NHSE1 and this means that delivery is subject to providers either opting-in or opting-out of this type of provision. Consequently, a key delivery component of the current roving service is to substantiate gaps in local provision where for example there is no viable primary care or other community option to support vulnerable patients. \nThis contract award has been made following Urgent Award Process (The Health Care Services (Provider Selection Regime) Regulations 2023, Regulation 14).\nThis contract will be for the period 1st April 2025 to 31st March 2026 (12 months).\nThe approximate lifetime value of the contract for 12 months is £512,000.",
        "awardCriteria": {
          "criteria": [
            {
              "name": "to address immediate risks to safety and quality of care",
              "type": "quality",
              "description": "100"
            },
            {
              "type": "price",
              "description": "0"
            }
          ]
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UKI"
          }
        ]
      }
    ],
    "title": "NHSE - SEL Provision of Covid-19 Vaccination Services",
    "status": "complete",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "NHSE - SEL Provision of Covid-19 Vaccination Services.",
    "classification": {
      "id": "85140000",
      "scheme": "CPV",
      "description": "Miscellaneous health services"
    },
    "procurementMethod": "limited",
    "mainProcurementCategory": "services",
    "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
    "procurementMethodRationale": "This contract has been awarded under the urgent circumstances provision of the Provider Selection Regime (PSR). This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.\nThis an incumbent provider within the SEL footprint, having taken part in previous campaigns.  A delay in national confirmation of funding created an unrealistic timeframe, in which a full procurement process would have left gaps in the provision of vaccines in the upcoming Spring campaign for large numbers of eligible individuals and/or groups. Discussion has taken place with all London ICB Programme Leads and it has been agreed that due to the serious time constraints and ensuring readiness for Spring, a direct award of 12 months to incumbent providers is essential. In addition, there is significant concern on the extent of reduction in Access and Inequalities funding, and with no surge budget this year, that providers will not come forward to support any shorter contract period as it is not financially viable for them.  It is recommended that regional approval is provided to issue direct award contracts to existing incumbent providers to enable the commissioning of outreach services for 2025/26.",
    "procurementMethodRationaleClassifications": [
      {
        "id": "D_OUTSIDE_SCOPE",
        "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
        "description": "The procurement falls outside the scope of application of the directive"
      }
    ]
  },
  "parties": [
    {
      "id": "GB-NHS-Q71",
      "name": "NHS England (London Region)",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKI",
        "locality": "London",
        "postalCode": "SE1 8UG",
        "countryName": "United Kingdom",
        "streetAddress": "Wellington House, 133-135 Waterloo Road"
      },
      "details": {
        "url": "https://www.england.nhs.uk/london/contact-us/",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "id": "Q71",
        "scheme": "GB-NHS",
        "legalName": "NHS England (London Region)"
      },
      "contactPoint": {
        "email": "hub.queries@nhs.net"
      }
    },
    {
      "id": "GB-NHS-RJ1",
      "name": "GUY'S AND ST THOMAS' NHS FOUNDATION TRUST",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UKI",
        "locality": "London",
        "countryName": "United Kingdom"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "id": "RJ1",
        "scheme": "GB-NHS",
        "legalName": "GUY'S AND ST THOMAS' NHS FOUNDATION TRUST"
      }
    },
    {
      "id": "GB-FTS-143400",
      "name": "NHS England (London Region)",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "London",
        "countryName": "United Kingdom"
      },
      "identifier": {
        "legalName": "NHS England (London Region)"
      }
    }
  ],
  "language": "en",
  "contracts": [
    {
      "id": "013955-2025-1",
      "value": {
        "amount": 512000,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "013955-2025-1",
      "dateSigned": "2025-02-25T00:00:00Z"
    }
  ],
  "description": "This contract has been awarded under the urgent circumstances provision of the Provider Selection Regime (PSR). This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.\nThis an incumbent provider within the SEL footprint, having taken part in previous campaigns.  A delay in national confirmation of funding created an unrealistic timeframe, in which a full procurement process would have left gaps in the provision of vaccines in the upcoming Spring campaign for large numbers of eligible individuals and/or groups. Discussion has taken place with all London ICB Programme Leads and it has been agreed that due to the serious time constraints and ensuring readiness for Spring, a direct award of 12 months to incumbent providers is essential. In addition, there is significant concern on the extent of reduction in Access and Inequalities funding, and with no surge budget this year, that providers will not come forward to support any shorter contract period as it is not financially viable for them.  It is recommended that regional approval is provided to issue direct award contracts to existing incumbent providers to enable the commissioning of outreach services for 2025/26.\nAward decision makers:\nFollowing a national CEG decision, the London Regional Executive team approved the request for an Outreach Service, Direct Award (12 months) to incumbent providers.\n- Regional Director of Finance, NHSE London\n- Regional Director of Commissioning, NHSE London\n- Director of Commissioning Finance, NHSE London\nApproval was also given by:\n- Operational Director - Covid-19 and Influenza Vaccination Programmes, NHSE London\n- Assistant Director of Delivery, NHSE London\n- Vaccine Programme Lead, NHSE London\nThere were no conflicts of interest identified in the decision making process.",
  "initiationType": "tender"
}